Sequence-selective recognition of
DNA duplexes is important for
a wide range of applications including regulating gene expression,
drug development, and genome editing. Many small molecules can bind
DNA duplexes with sequence selectivity. It remains as a challenge
how to reliably and conveniently obtain the detailed structural information
on DNA–molecule interactions because such information is critically
needed for understanding the underlying rules of DNA–molecule
interactions. If those rules were understood, we could design molecules
to recognize DNA duplexes with a sequence preference and intervene
in related biological processes, such as disease treatment. Here,
we have demonstrated that DNA crystal engineering is a potential solution.
A molecule-binding DNA sequence is engineered to self-assemble into
highly ordered DNA crystals. An X-ray crystallographic study of molecule–DNA
cocrystals reveals the structural details on how the molecule interacts
with the DNA duplex. In this approach, the DNA will serve two functions:
(1) being part of the molecule to be studied and (2) forming the crystal
lattice. It is conceivable that this method will be a general method
for studying drug/peptide–DNA interactions. The resulting DNA
crystals may also find use as separation matrices, as hosts for catalysts,
and as media for material storage.